跳至主要内容
临床试验/CTRI/2021/04/032956
CTRI/2021/04/032956招募中4 期

Prospective Randomized Clinical Study to Evaluate the Effect of DiabetEaze Powder in Nutritional Management of Pre-Diabetes and Type 2 Diabetes Mellitus

Arun Visakh Nair Pankajakasthuri Herbals India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Willing to sign consent form.
  • 2.Men and Women aged 40 years or greater and not older than 65 years.
  • 3.Subjects with clinical evidence of Type 2 Diabetes Mellitus.
  • 4.Subjects of Pre-Diabetes with HbA1c range between 5.7% and 6.4% and/or OGTT range between 140 mg/dl and 199 mg/dl.

排除标准

  • 1.Presence of conditions like Medical, Psychological, Social or Alcohol abuse that would interfere with participation in the trial.
  • 2.Subjects with known allergy to any of the ingredients of the drug product.
  • 3.Pregnant or Lactating women.
  • 4.Subjects with Type1 Diabetes Mellitus.
  • 5.Subjects undergoing Insulin therapy.
  • 6.Other conditions like CKD, Malignancies etc.
  • 7.Post-surgical cases mainly GI diseases.
  • 8.Patients under Steroid intake.

研究者

发起方
Arun Visakh Nair Pankajakasthuri Herbals India Pvt Ltd

相似试验